Invalid Symbol

Stock Research for REGN

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


REGN Stock Chart & Research Data

The REGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the REGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


REGN Due diligence Resources & Stock Charts

The REGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View REGN Detailed Price Forecast - CNN Money CNN View REGN Detailed Summary - Google Finance
Yahoo View REGN Detailed Summary - Yahoo! Finance Zacks View REGN Stock Research & Analysis -

Stock Analysis

TradeIdeas View REGN Trends & Analysis - Trade-Ideas Barrons View REGN Major Holders - Barrons
NASDAQ View REGN Call Transcripts - NASDAQ Seeking View REGN Breaking News & Analysis - Seeking Alpha
Spotlight View REGN Annual Report - OTC Report View REGN OTC Short Report -
TradeKing View REGN Fundamentals - TradeKing Charts View REGN SEC Filings - Bar Chart
WSJ View Historical Prices for REGN - The WSJ Morningstar View Performance/Total Return for REGN - Morningstar
MarketWatch View the Analyst Estimates for REGN - MarketWatch CNBC View the Earnings History for REGN - CNBC
StockMarketWatch View the REGN Earnings - StockMarketWatch MacroAxis View REGN Buy or Sell Recommendations - MacroAxis
Bullish View the REGN Bullish Patterns - American Bulls Short Pains View REGN Short Pain Metrics -

Social Media Mentions

StockTwits View REGN Stock Mentions - StockTwits PennyStocks View REGN Stock Mentions - PennyStockTweets
Twitter View REGN Stock Mentions - Twitter Invest Hub View REGN Investment Forum News - Investor Hub
Yahoo View REGN Stock Mentions - Yahoo! Message Board Seeking Alpha View REGN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for REGN - Insider Cow View Insider Transactions for REGN - Insider Cow
CNBC View REGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for REGN - OTC Markets
Yahoo View Insider Transactions for REGN - Yahoo! Finance NASDAQ View Institutional Holdings for REGN - NASDAQ

Stock Charts

FinViz View REGN Stock Insight & Charts - StockCharts View REGN Investment Charts -
BarChart View REGN Stock Overview & Charts - BarChart Trading View View REGN User Generated Charts - Trading View

Latest Financial News for REGN

Regeneron shares slip after Canaccord downgrades stock, slashes price target 32%
Posted on Wednesday February 21, 2018

Shares of Regeneron Inc. slid Wednesday, after Canaccord downgraded the stock to hold from buy and slashed its price target by 32% to $356 from $522. Analysts led by John Newman said they were concerned ...

Canaccord Slices Regeneron Price Target 32% On Eylea, Dupixent Challenges
Posted on Wednesday February 21, 2018

Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) shares fell 31 percent over the last six months, and the company's headwinds appear unending. The biotech firm lost an advocate Wednesday on the basis of a ...

Regeneron's Eylea Has Mysterious Rise in Side Effect Reports
Posted on Wednesday February 21, 2018

Doctors say they’re seeing an unexplained increase in a rare, frightening side effect in patients getting Regeneron Pharmaceuticals Inc.’s top-selling product, the blockbuster eye drug Eylea.

See what the IHS Markit Score report has to say about Regeneron Pharmaceuticals Inc.
Posted on Wednesday February 21, 2018

Regeneron Pharmaceuticals Inc NASDAQ/NGS:REGN

Regeneron Annual Report, Earnings Forecast And Stock Valuation
Seeking Alpha - Feb 19, 2018
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a fully integrated biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases.

Regeneron - Levels To Regenerate?
Seeking Alpha - Feb 11, 2018
Regeneron Pharmaceuticals (REGN) has been on my watchlist for a while. I looked at the shares in September when shares were trading at $430 and updated my cautious thesis when the company released its third-quarter results. At the time, shares traded ...

Regeneron Pharmaceuticals Inc. (REGN) Dips 2.74% for February 20 - Feb 20, 2018
Among the S&P 500's biggest fallers on Tuesday February 20 was Regeneron Pharmaceuticals Inc. (REGN). The stock experienced a 2.74% decline to $323.04 with 821,651 shares changing hands.
Jefferies Group Weighs in on Regeneron Pharmaceuticals Inc's FY2019 Earnings ... - StockNewsTimes
KBC Group NV Sells 1731 Shares of Regeneron Pharmaceuticals Inc (REGN) - The Ledger Gazette

Regeneron Investment: Healthcare With Wealthcare
Seeking Alpha - Feb 5, 2018
One of the most risky investments are biomedical companies. An investor will need to track the research and development of drugs and closely follow the various phases of the FDA approval process.

Enter a stock symbol to view the stock details.